Cytek Biosciences Introduces The Cytek Orion Reagent Cocktail Preparation System, The First-Of-Its-Kind Automated Cocktail Preparation Instrument For Flow Cytometry
Portfolio Pulse from Benzinga Newsdesk
Cytek Biosciences, Inc. (NASDAQ:CTKB) has launched the Cytek Orion reagent cocktail preparation system, an automated instrument for flow cytometry that simplifies lab workflows, ensures consistent results, and reduces errors. The system can handle up to 60 reagents per cocktail and is compatible with the Cytek ecosystem and other systems. It offers cost savings and reduces repetitive motion injuries. The CEO, Wenbin Jiang, highlights its unique focus on cocktail making, cost-effectiveness, and potential to expand into new markets.
December 21, 2023 | 2:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cytek Biosciences introduced the Cytek Orion, an automated system for preparing reagent cocktails in flow cytometry, which could streamline lab operations and reduce errors.
The introduction of the Cytek Orion system is likely to be viewed positively by investors as it represents an innovative product that could lead to operational efficiencies, cost savings, and potentially expand Cytek Biosciences' market reach. This could result in increased sales and customer interest, positively impacting CTKB's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100